Paul Stabila

1.9k total citations
17 papers, 1.4k citations indexed

About

Paul Stabila is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cellular and Molecular Neuroscience. According to data from OpenAlex, Paul Stabila has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Paul Stabila's work include Retinal Development and Disorders (6 papers), Cellular transport and secretion (4 papers) and Neuroscience and Neural Engineering (3 papers). Paul Stabila is often cited by papers focused on Retinal Development and Disorders (6 papers), Cellular transport and secretion (4 papers) and Neuroscience and Neural Engineering (3 papers). Paul Stabila collaborates with scholars based in United States, United Kingdom and Switzerland. Paul Stabila's co-authors include Andrew Hiatt, Julian K‐C., Thomas Lehner, Weng Tao, Konrad Kauper, Keith E. Mostov, Craig J. van Dolleweerd, Mich B. Hein, Nicholas D. Vine and Fei Wang and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Biotechnology.

In The Last Decade

Paul Stabila

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Stabila United States 13 1.1k 511 272 260 224 17 1.4k
Alexander C. Theos United States 16 1.2k 1.1× 29 0.1× 92 0.3× 276 1.1× 61 0.3× 21 1.8k
Minoru Ujita Japan 18 764 0.7× 94 0.2× 48 0.2× 11 0.0× 58 0.3× 35 1.1k
Davide Foletti United States 21 1.2k 1.1× 36 0.1× 290 1.1× 11 0.0× 294 1.3× 26 1.7k
Hanna P. Lesch Finland 18 940 0.9× 57 0.1× 68 0.3× 18 0.1× 28 0.1× 35 1.3k
Lolita M. Corpuz United States 12 441 0.4× 13 0.0× 364 1.3× 55 0.2× 48 0.2× 15 974
Kristina Forsman Sweden 14 987 0.9× 15 0.0× 99 0.4× 378 1.5× 145 0.6× 15 1.2k
Ryota Hayashi Japan 15 417 0.4× 70 0.1× 16 0.1× 31 0.1× 36 0.2× 60 713
Erin R. Burnight United States 19 1.1k 1.0× 9 0.0× 108 0.4× 171 0.7× 188 0.8× 37 1.3k
Shaohua Yao China 21 1.1k 1.0× 37 0.1× 23 0.1× 22 0.1× 30 0.1× 58 1.3k
Amena Rahman United States 14 400 0.4× 105 0.2× 32 0.1× 5 0.0× 59 0.3× 17 723

Countries citing papers authored by Paul Stabila

Since Specialization
Citations

This map shows the geographic impact of Paul Stabila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Stabila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Stabila more than expected).

Fields of papers citing papers by Paul Stabila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Stabila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Stabila. The network helps show where Paul Stabila may publish in the future.

Co-authorship network of co-authors of Paul Stabila

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Stabila. A scholar is included among the top collaborators of Paul Stabila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Stabila. Paul Stabila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kauper, Konrad, et al.. (2013). Continuous Intraocular Drug Delivery over 5 ½ Years: Ciliary Neurotrophic Factor (CNTF)Production by Encapsulated Cell Technology Implants Treating Patients with Retinitis Pigmentosa and Geographic Atrophy. Investigative Ophthalmology & Visual Science. 54(15). 3295–3295. 2 indexed citations
2.
Kauper, Konrad, et al.. (2012). Two-Year Intraocular Delivery of Ciliary Neurotrophic Factor by Encapsulated Cell Technology Implants in Patients with Chronic Retinal Degenerative Diseases. Investigative Ophthalmology & Visual Science. 53(12). 7484–7484. 139 indexed citations
3.
Wen, Rong, Weng Tao, Lingyu Luo, et al.. (2011). Regeneration of Cone Outer Segments Induced by CNTF. Advances in experimental medicine and biology. 723. 93–99. 12 indexed citations
4.
Stabila, Paul, et al.. (2011). Vascular endothelial growth factor in diabetic and nondiabetic canine cataract patients. Veterinary Ophthalmology. 14(2). 93–99. 9 indexed citations
5.
Kauper, Konrad, et al.. (2010). Sustained Intraocular Delivery of a Receptor Antibody Using an Encapsulated Cell Technology Implant. Investigative Ophthalmology & Visual Science. 51(13). 5317–5317. 1 indexed citations
6.
Li, Yiwen, Weng Tao, Lingyu Luo, et al.. (2010). CNTF Induces Regeneration of Cone Outer Segments in a Rat Model of Retinal Degeneration. PLoS ONE. 5(3). e9495–e9495. 99 indexed citations
7.
Thanos, Christopher G., William J. Bell, P. O'Rourke, et al.. (2004). Sustained Secretion of Ciliary Neurotrophic Factor to the Vitreous, Using the Encapsulated Cell Therapy-Based NT-501 Intraocular Device. Tissue Engineering. 10(11-12). 1617–1622. 65 indexed citations
8.
Tao, Weng, Rong Wen, Moses Goddard, et al.. (2002). Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.. PubMed. 43(10). 3292–8. 247 indexed citations
9.
Hoane, Michael R., Kamal D. Puri, Paul Stabila, et al.. (2000). Mammalian-Cell-Produced Neurturin (NTN) Is More Potent Than Purified Escherichia coli-Produced NTN. Experimental Neurology. 162(1). 189–193. 14 indexed citations
10.
Joberty, Gérard, Paul Stabila, Thierry Coppola, Ian G. Macara, & Romano Regazzi. (1999). High affinity Rab3 binding is dispensable for Rabphilin-dependent potentiation of stimulated secretion. Journal of Cell Science. 112(20). 3579–3587. 30 indexed citations
11.
Stabila, Paul, et al.. (1998). Cell surface expression of a human IgC Fc chimera activates macrophages through Fc receptors. Nature Biotechnology. 16(13). 1357–1360. 16 indexed citations
12.
Stabila, Paul, et al.. (1997). Importance of the Rab3a‐GTP Binding Domain for the Intracellular Stability and Function of Rabphilin3a in Secretion. Journal of Neurochemistry. 69(1). 164–173. 15 indexed citations
13.
Stabila, Paul, et al.. (1996). Role of the Rab3A-Binding Domain in Targeting of Rabphilin-3A to Vesicle Membranes of PC12 Cells. Molecular and Cellular Biology. 16(9). 4985–4995. 49 indexed citations
14.
Brondyk, William, et al.. (1995). Interaction Cloning of Rabin3, a Novel Protein That Associates with the Ras-Like GTPase Rab3A. Molecular and Cellular Biology. 15(3). 1137–1143. 71 indexed citations
15.
K‐C., Julian, Andrew Hiatt, Mich B. Hein, et al.. (1995). Generation and Assembly of Secretory Antibodies in Plants. Science. 268(5211). 716–719. 413 indexed citations
16.
K‐C., Julian, et al.. (1994). Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants. European Journal of Immunology. 24(1). 131–138. 145 indexed citations
17.
Nicolaou, K. C., et al.. (1993). Cell-specific regulation of apoptosis by designed enediynes.. Proceedings of the National Academy of Sciences. 90(8). 3142–3146. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026